应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01530 三生制药
交易中 03-11 14:34:31
8.500
+0.360
+4.42%
最高
8.770
最低
8.010
成交量
6,771万
今开
8.010
昨收
8.140
日振幅
9.34%
总市值
203.62亿
流通市值
203.62亿
总股本
23.96亿
成交额
5.80亿
换手率
2.83%
流通股本
23.96亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
三生制药盘中异动 早盘大幅上涨5.04%
市场透视 · 09:39
三生制药盘中异动 早盘大幅上涨5.04%
三生制药03月10日获主力加仓1034万元
市场透视 · 03-10 16:17
三生制药03月10日获主力加仓1034万元
港股异动 | 三生制药(01530)盘中涨近8% SSGJ707临床数据优异 海外BD预期提供较大弹性
智通财经 · 03-10 14:46
港股异动 | 三生制药(01530)盘中涨近8% SSGJ707临床数据优异 海外BD预期提供较大弹性
港股创新药ETF规模、份额连续两日创新高,三生制药涨超5%,机构:创新药板块情绪回暖
21世纪经济报道 · 03-10 10:17
港股创新药ETF规模、份额连续两日创新高,三生制药涨超5%,机构:创新药板块情绪回暖
港股创新药ETF飘红,三生制药涨超1%,机构:3月重点关注创新药
21世纪经济报道 · 03-07
港股创新药ETF飘红,三生制药涨超1%,机构:3月重点关注创新药
三生制药盘中异动 早盘股价大涨5.15%报7.560港元
市场透视 · 03-05
三生制药盘中异动 早盘股价大涨5.15%报7.560港元
三生制药03月04日主力净流入52万元 散户资金抛售
市场透视 · 03-04
三生制药03月04日主力净流入52万元 散户资金抛售
三生制药盘中异动 快速拉升5.06%
市场透视 · 02-27
三生制药盘中异动 快速拉升5.06%
三生制药盘中异动 快速上涨5.00%报7.140港元
市场透视 · 02-26
三生制药盘中异动 快速上涨5.00%报7.140港元
招银国际:内地药品价格政策有望优化 医疗AI加速商业化落地
智通财经 · 02-25
招银国际:内地药品价格政策有望优化 医疗AI加速商业化落地
南向资金2月19日净卖出三生制药120.95万股 连续7日减持
市场透视 · 02-20
南向资金2月19日净卖出三生制药120.95万股 连续7日减持
三生制药(01530)出现大手卖出500万股,成交价$6.4,涉资3.2千万
阿斯达克财经 · 02-20
三生制药(01530)出现大手卖出500万股,成交价$6.4,涉资3.2千万
中国内地投资者周二港股通净买入额创四年来最高
金融界 · 02-19
中国内地投资者周二港股通净买入额创四年来最高
南向资金2月17日净卖出三生制药24.10万股 连续5日减持
市场透视 · 02-18
南向资金2月17日净卖出三生制药24.10万股 连续5日减持
大健康行业周报 | 三生制药与百利天恒达成临床研究合作;湖北再添一项医疗政府基金
保观 · 02-17
大健康行业周报 | 三生制药与百利天恒达成临床研究合作;湖北再添一项医疗政府基金
三生制药02月17日主力资金流出51万元 连续3日减仓
市场透视 · 02-17
三生制药02月17日主力资金流出51万元 连续3日减仓
三生制药盘中异动 下午盘快速跳水5.05%
市场透视 · 02-17
三生制药盘中异动 下午盘快速跳水5.05%
【券商聚焦】华源证券首予三生制药(01530)“买入”评级 指公司核心品种稳健增长
金吾财讯 · 02-17
【券商聚焦】华源证券首予三生制药(01530)“买入”评级 指公司核心品种稳健增长
三生制药:核心品种稳健增长 创新管线迈入收获期
华源证券 · 02-17
三生制药:核心品种稳健增长 创新管线迈入收获期
三生制药02月11日遭主力抛售236万元
市场透视 · 02-11
三生制药02月11日遭主力抛售236万元
暂无数据
公司概况
公司名称:
三生制药
所属市场:
SEHK
上市日期:
--
主营业务:
三生制药是一家主要从事开发、生产、营销及销售医药产品的投资控股公司。该公司的主要产品包括重组人血小板生成素产品,肿瘤坏死因子α抑制剂产品以及重组人促红素等。产品以特比澳,益赛普,益比奥,以及赛博尔等品牌销售。该公司在国内市场和斯里兰卡、多米尼加共和国及泰国等海外市场销售产品。该公司的子公司包括集思有限公司,香港三生医疗有限公司和沈阳三生制药有限责任公司。该公司通过其子公司还从事项目管理及咨询业务。
发行价格:
--
{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"三生制药","latestPrice":8.5,"timestamp":1741674870629,"preClose":8.14,"halted":0,"volume":67714500,"delay":0,"floatShares":2395573912,"shares":2395573912,"eps":0.6811940841735672,"marketStatus":"交易中","change":0.36,"latestTime":"03-11 14:34:31","open":8.01,"high":8.77,"low":8.01,"amount":579771342,"amplitude":0.093366,"askPrice":8.51,"askSize":26500,"bidPrice":8.5,"bidSize":7500,"shortable":3,"etf":0,"ttmEps":0.7306480437491262,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1741680600000},"marketStatusCode":2,"adr":0,"exchange":"SEHK","adjPreClose":8.14,"dividendRate":0.02855,"openAndCloseTimeList":[[1741656600000,1741665600000],[1741669200000,1741680000000]],"volumeRatio":2.467529,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01530/tweets","defaultTab":"tweets","newsList":[{"id":"2518734777","title":"三生制药盘中异动 早盘大幅上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518734777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518734777?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:39","pubTimestamp":1741657156,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘09时39分,三生制药股票出现异动,股价急速拉升5.04%。截至发稿,该股报8.550港元/股,成交量977.8万股,换手率0.41%,振幅6.63%。三生制药股票所在的药品行业中,整体跌幅为0.20%。其相关个股中,三生制药、九源基因、开拓药业-B涨幅较大,振幅较大的相关个股有九源基因、三生制药、联康生物科技集团,振幅分别为7.50%、6.63%、4.00%。消息层面,截至09时39分,《三生制药SSGJ707 II期数据积极,创新药进入收获期》资讯为影响三生制药的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031109391698a33193&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031109391698a33193&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","BK1583","01530"],"gpt_icon":0},{"id":"2518212998","title":"三生制药03月10日获主力加仓1034万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518212998","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518212998?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:17","pubTimestamp":1741594657,"startTime":"0","endTime":"0","summary":"03月10日, 三生制药股价涨7.53%,报收8.14元,成交金额5.50亿元,换手率2.88%,振幅7.27%,量比2.50。三生制药今日主力资金净流入1034万元,上一交易日主力净流入3955万元。该股近5个交易日上涨14.66%,主力资金累计净流入3043万元;近20日主力资金累计净流入11万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310171016a269bf25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310171016a269bf25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1593","BK1161","01530"],"gpt_icon":0},{"id":"2518729883","title":"港股异动 | 三生制药(01530)盘中涨近8% SSGJ707临床数据优异 海外BD预期提供较大弹性","url":"https://stock-news.laohu8.com/highlight/detail?id=2518729883","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518729883?lang=zh_cn&edition=full","pubTime":"2025-03-10 14:46","pubTimestamp":1741589162,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,三生制药盘中涨近8%,截至发稿,涨6.34%,报8.05港元,成交额4.47亿港元。东吴证券表示,SGJ-707正在推进包括单药一线治疗PD-L1阳性的NSCLC、联合化疗治疗一线NSCLC,一线和后线转移性结直肠癌、以及包括子宫内膜癌、卵巢癌等在内的晚期妇科肿瘤等4项II期临床研究,近期于JPM大会上披露的II期临床阶段性分析数据显示了707显著的抗肿瘤活性和良好的安全性,具备同类最佳潜力。预计SSGJ-707国内销售峰值约40亿元,海外销售峰值有望达到45亿美金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01530","BK1583","BK1593","BK1161"],"gpt_icon":0},{"id":"2518251237","title":"港股创新药ETF规模、份额连续两日创新高,三生制药涨超5%,机构:创新药板块情绪回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2518251237","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518251237?lang=zh_cn&edition=full","pubTime":"2025-03-10 10:17","pubTimestamp":1741573035,"startTime":"0","endTime":"0","summary":"相关ETF方面,港股创新药ETF一度涨超1.1%,截至发稿飘红,涨0.27%,换手率近16%,成交额近8000万元,溢折率0.41%,盘中频现溢价交易。数据显示,港股创新药ETF最新流通规模、最新流通份额连续两日创历史新高。港股创新药ETF紧密跟踪港股通创新药指数,该指数反映港股通生物科技产业上市公司的运行特征。近期受益于海外流动性因素,创新药板块情绪回暖,前期的超跌有所修复,市场风险偏好逐步回升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310102505abf20fd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310102505abf20fd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06978","BK1583","01530","BK1593"],"gpt_icon":0},{"id":"2517144658","title":"港股创新药ETF飘红,三生制药涨超1%,机构:3月重点关注创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2517144658","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517144658?lang=zh_cn&edition=full","pubTime":"2025-03-07 10:11","pubTimestamp":1741313462,"startTime":"0","endTime":"0","summary":"3月7日,港股低开低走,国证港股通创新药指数走低。相关ETF方面,港股创新药ETF截至发稿飘红,涨0.18%。成分股方面,云顶新耀-b涨超5%,三生制药涨超1%,宜明昂科-b、康哲药业、药明康德、金斯瑞生物科技等股跟涨。港股创新药ETF紧密跟踪港股通创新药指数,该指数反映港股通生物科技产业上市公司的运行特征。兴业证券发布医药2025年3月投资月报称,医药板块景气度回升,看好创新药、创新药产业链、AI医疗三大方向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307101500a26346de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307101500a26346de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1161","BK1574","01530","BK1583","BK1593"],"gpt_icon":0},{"id":"2517932561","title":"三生制药盘中异动 早盘股价大涨5.15%报7.560港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517932561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517932561?lang=zh_cn&edition=full","pubTime":"2025-03-05 09:32","pubTimestamp":1741138349,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时32分,三生制药股票出现异动,股价大幅上涨5.15%。截至发稿,该股报7.560港元/股,成交量291.45万股,换手率0.12%,振幅4.45%。资金方面,该股资金流入982.543万港元,流出665.848万港元。三生制药股票所在的药品行业中,整体涨幅为0.07%。其相关个股中,三生制药、翰森制药、联邦制药涨幅较大,振幅较大的相关个股有三生制药、翰森制药、联邦制药,振幅分别为4.45%、3.72%、3.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093229a25fbee3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093229a25fbee3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","BK1583","01530"],"gpt_icon":0},{"id":"2516625906","title":"三生制药03月04日主力净流入52万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2516625906","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516625906?lang=zh_cn&edition=full","pubTime":"2025-03-04 17:39","pubTimestamp":1741081192,"startTime":"0","endTime":"0","summary":"03月04日, 三生制药股价涨0.42%,报收7.19元,成交金额1.33亿元,换手率0.78%,振幅5.03%,量比0.59。三生制药今日主力资金净流入52万元,上一交易日主力净流出2357万元。该股近5个交易日上涨6.03%,主力资金累计净流出1494万元;近20日主力资金累计净流出3983万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304175017a25ea7da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304175017a25ea7da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1593","BK1161","01530"],"gpt_icon":0},{"id":"2514819482","title":"三生制药盘中异动 快速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514819482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514819482?lang=zh_cn&edition=full","pubTime":"2025-02-27 09:41","pubTimestamp":1740620499,"startTime":"0","endTime":"0","summary":"2025年02月27日早盘09时41分,三生制药股票出现异动,股价急速拉升5.06%。截至发稿,该股报7.480港元/股,成交量604.5万股,换手率0.25%,振幅5.20%。三生制药股票所在的药品行业中,整体跌幅为0.02%。其相关个股中,开拓药业-B、君圣泰医药-B、三生制药涨幅较大,振幅较大的相关个股有开拓药业-B、君圣泰医药-B、德琪医药-B,振幅分别为11.11%、7.83%、5.20%。三生制药公司简介:投资控股,及本集团主要在中国从事开发、生产、营销及销售生物医药产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227094139989433b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227094139989433b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","BK1583","01530"],"gpt_icon":0},{"id":"2514500897","title":"三生制药盘中异动 快速上涨5.00%报7.140港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514500897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514500897?lang=zh_cn&edition=full","pubTime":"2025-02-26 13:53","pubTimestamp":1740549194,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘13时53分,三生制药股票出现波动,股价急速拉升5.00%。截至发稿,该股报7.140港元/股,成交量1437.75万股,换手率0.60%,振幅6.18%。资金方面,该股资金流入6084.78万港元,流出2286.93万港元。机构评级方面,在所有4家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。三生制药股票所在的药品行业中,整体涨幅为0.50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261353159630c12f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261353159630c12f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1583","01530","BK1161"],"gpt_icon":0},{"id":"2514129084","title":"招银国际:内地药品价格政策有望优化 医疗AI加速商业化落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2514129084","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514129084?lang=zh_cn&edition=full","pubTime":"2025-02-25 09:50","pubTimestamp":1740448233,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,招银国际发布研报称,维持内地医药行业“优于大市评级”。MSCI中国医疗指数2025年初至今累计上涨11.5%,跑输MSCI中国指数1.2%。受益于国内药品价格政策优化、国内宏观环境改善以及海外降息预期,医药行业有望在2025年继续迎来估值修复。报告指,丙类医保目录年内即将落地,创新药将覆盖获得更好的支付环境;医疗设备招标加速复苏,将推动国产医疗设备企业盈利复苏。该行看好行业估值修复,推荐买入信达生物(01801)、百济神州(06160)、三生制药(01530)、联影医疗(688271.SH)、巨子生物(02367)、药明康德(02359)、科伦博泰生物-B(06990)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","BK1161","BK1207","BK1141","LU2242644610.SGD","LU0588546209.SGD","LU1046422090.SGD","LU2045819591.USD","LU0307460666.USD","BK1500","01530","BK1576","06160","LU2328871848.SGD","LU0052750758.USD","150261","LU0320764599.SGD","BK1589","BK1593","02367","BK1588","LU2125910500.SGD","LU0708995583.HKD","02359","01801","BK1583","LU1969619763.USD"],"gpt_icon":0},{"id":"2512506734","title":"南向资金2月19日净卖出三生制药120.95万股 连续7日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2512506734","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512506734?lang=zh_cn&edition=full","pubTime":"2025-02-20 09:30","pubTimestamp":1740015020,"startTime":"0","endTime":"0","summary":"2月19日,南向资金减持三生制药120.95万股连续7日减持。截止当日收盘,港股通共持有三生制药60439.19万股,占流通股25.22%。三生制药近5个交易日上涨4.55%,港股通累计减持673.34万股;近20个交易日上涨7.58%,港股通累计减持1921.96万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220093158abd57c6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220093158abd57c6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","01530","BK1593"],"gpt_icon":0},{"id":"2512457800","title":"三生制药(01530)出现大手卖出500万股,成交价$6.4,涉资3.2千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2512457800","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512457800?lang=zh_cn&edition=full","pubTime":"2025-02-20 09:00","pubTimestamp":1740013200,"startTime":"0","endTime":"0","summary":"[大手成交]三生制药(01530)在上午09:00出现大手卖出,成交量为500万,成交价为港币$6.4,涉资3.2千万。至目前为止,股价无升跌,今日最高价为$6.4,而最低价为$6.4,总成交量为500万股,总成交金额港币$3.2千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2502201/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01530","BK1583","BK1593","BK1161"],"gpt_icon":0},{"id":"2512111961","title":"中国内地投资者周二港股通净买入额创四年来最高","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111961","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512111961?lang=zh_cn&edition=full","pubTime":"2025-02-19 07:37","pubTimestamp":1739921873,"startTime":"0","endTime":"0","summary":"中国内地投资者周二通过港股通净买入224亿港元的香港股票,继续推动DeepSeek引发的科技股涨势。彭博数据显示,这是自2021年初以来最大单日净买入,也是有纪录以来第四高。恒生科技指数当日大涨2.5%,有望连续第六周上涨。内地资金大量涌入香港股市,已推动A股市场相较港股的溢价幅度缩小至约34%,这使得一项A-H股溢价指数接近在过去总会触发反弹的底部,引发了香港上市中资股跑赢内地股票的幅度可能缩小的担忧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01921","06699","BK1133","03360","02533","02688","00300","02157","09987","00826","00008","00548","00384","00152","01024","00939","09969","02618","03969","03618","01952","00267","00220","03988","01199","06160","06680","00142","00270","SG9999002463.SGD","00005","01691","02208","01347","00412","03690","01052","02005","01357","01772","02607","02015","00257","02016","09626","09992","00003","01860","00981","09922","01579","02268","00175","00728","02096","00316","00013","02018","02282","02057","03650","00189","01810","00303","03328","00038","02333","02338","01310","02121","00107","03692","00148","00327","00853","01128","01193","01907","09696","00425","01530","06618","02600","00392","00512","00777","06821","09885","00467","01211","02367","06990","00751","02155","06855","01071","06818","03888","09899","00762","00788","01138","02162","02382","02386","01888","01675","09995","01405","00546","01787","06127","02883","03933","01519","02291","03396","01876","01789","01963","09926","00241","03369","06181","00144","01818","01513","HSCEI","01177","01735","09868","02269","09858","BK1536","00772","01855","00371","00576","01341","BK1589","02400","06198","01070","01112","01658","00819","00666","01766","02402","02359","00855","01929","00868","00836","03311","00177","06186","00659","02465","00006","02380","01618","06060","00014","01119","02601","09988","00288","01686","HSTECH","03968","02498","BK1506","00861","06069","02099","02158","00991","06690","01066","00856","01093","00590","01541","01585","00867","02105","09923","06936","02171","06616","02172","01558","09688","09880","09890","00293","06808","01919","02186","00317","06110","03800","03918","03606"],"gpt_icon":0},{"id":"2512905206","title":"南向资金2月17日净卖出三生制药24.10万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2512905206","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512905206?lang=zh_cn&edition=full","pubTime":"2025-02-18 09:30","pubTimestamp":1739842217,"startTime":"0","endTime":"0","summary":"2月17日,南向资金减持三生制药24.10万股连续5日减持。截止当日收盘,港股通共持有三生制药60842.69万股,占流通股25.38%。港股通减持金额前五个股分别为腾讯控股、小米集团-W、比亚迪股份、比亚迪电子、中国海洋石油。三生制药近5个交易日下跌0.15%,港股通累计减持539.54万股;近20个交易日上涨13.09%,港股通累计减持1544.61万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218093155abd2e122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218093155abd2e122&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1161","BK1583","BK1593"],"gpt_icon":0},{"id":"2512942959","title":"大健康行业周报 | 三生制药与百利天恒达成临床研究合作;湖北再添一项医疗政府基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2512942959","media":"保观","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512942959?lang=zh_cn&edition=full","pubTime":"2025-02-17 19:31","pubTimestamp":1739791871,"startTime":"0","endTime":"0","summary":"保观 |聚焦保险创新国内篇行业动态三生制药与百利天恒达成临床研究合作2月14日,百利天恒宣布,公司与三生制药近日达成《战略合作协议》,双方将共同推进BL-B01D1和707联合用药,在国内用于实体瘤的治疗,探索双抗+双抗ADC在肿瘤治疗上未被发掘的潜在价值。湖北再添一项医疗政府基金近日获悉,湖北省政府投资引导基金支持设立的总规模10亿元湖北泰誉五期生命健康产业投资基金正式落地,助力“51020”万亿级大健康产业发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217203820abd23eef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217203820abd23eef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688506","01530","159891"],"gpt_icon":0},{"id":"2512911410","title":"三生制药02月17日主力资金流出51万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2512911410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512911410?lang=zh_cn&edition=full","pubTime":"2025-02-17 16:17","pubTimestamp":1739780247,"startTime":"0","endTime":"0","summary":"02月17日, 三生制药股价跌3.71%,报收6.48元,成交金额1.06亿元,换手率0.67%,振幅6.09%,量比1.18。三生制药今日主力资金净流出51万元,连续3日净流出,上一交易日主力净流出489万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为47.37%,平均跌幅为1.75%。该股近5个交易日下跌0.31%,主力资金累计净流出1182万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出4168万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217161836a248ebff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217161836a248ebff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","01530","BK1583"],"gpt_icon":0},{"id":"2512992066","title":"三生制药盘中异动 下午盘快速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512992066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512992066?lang=zh_cn&edition=full","pubTime":"2025-02-17 13:50","pubTimestamp":1739771403,"startTime":"0","endTime":"0","summary":"2025年02月17日下午盘13时50分,三生制药股票出现波动,股价急速跳水5.05%。截至发稿,该股报6.390港元/股,成交量900.75万股,换手率0.38%,振幅6.09%。资金方面,该股资金流入1814.76万港元,流出2960.34万港元。机构评级方面,在所有3家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。三生制药股票所在的药品行业中,整体涨幅为0.09%。三生制药公司简介:投资控股,及本集团主要在中国从事开发、生产、营销及销售生物医药产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217135004abd1cd75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217135004abd1cd75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01530","BK1593","BK1583"],"gpt_icon":0},{"id":"2512699956","title":"【券商聚焦】华源证券首予三生制药(01530)“买入”评级 指公司核心品种稳健增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2512699956","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512699956?lang=zh_cn&edition=full","pubTime":"2025-02-17 12:19","pubTimestamp":1739765987,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华源证券发研报指,三生制药 目前已有40余种上市产品,覆盖肾科、肿瘤科、自身免疫性疾病、眼科及皮肤科等多种治疗领域,其中核心品种特比澳、蔓迪系列等有望持续稳健增长。该行表示,多元化业务结构+成熟上市产品体系,驱动公司核心板块持续稳健增长。1)制药板块:特比澳作为公司第一大单品,24H1实现同比22.6%的高速增长,且2024年医保谈判成功零降价续约并新增儿童ITP适应症,未来有望持续增长。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953266","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","01530"],"gpt_icon":0},{"id":"2512703991","title":"三生制药:核心品种稳健增长 创新管线迈入收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2512703991","media":"华源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512703991?lang=zh_cn&edition=full","pubTime":"2025-02-17 00:00","pubTimestamp":1739721600,"startTime":"0","endTime":"0","summary":"三生制药成立于1993 年,并于2015 年在香港联交所上市。目前公司已有40 余种上市产品,覆盖肾科、肿瘤科、自身免疫性疾病、眼科及皮肤科等多种治疗领域,其中核心品种特比澳、蔓迪系列等有望持续稳健增长。1)制药板块:特比澳作为公司第一大单品,24H1 实现同比22.6%的高速增长,且2024 年医保谈判成功零降价续约并新增儿童ITP 适应症,未来有望持续增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217131524abd1c60a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217131524abd1c60a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1583","01530","BK1161"],"gpt_icon":0},{"id":"2510938874","title":"三生制药02月11日遭主力抛售236万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510938874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510938874?lang=zh_cn&edition=full","pubTime":"2025-02-11 16:16","pubTimestamp":1739261810,"startTime":"0","endTime":"0","summary":"02月11日, 三生制药股价跌2.16%,报收6.35元,成交金额5356万元,换手率0.35%,振幅2.93%,量比0.90。三生制药今日主力资金净流出236万元,连续5日净流出,上一交易日主力净流出77万元。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为71.43%,平均跌幅为1.74%。该股近5个交易日上涨4.26%,主力资金累计净流出1239万元;近20日主力资金累计净流出4078万元,其中净流出天数为15日。该股主力净额占比0.02%,港股市场排名2365/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211162006abcaa738&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211162006abcaa738&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","BK1583","01530"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":0.1369},{"period":"1month","weight":0.2659},{"period":"3month","weight":0.3236},{"period":"6month","weight":0.4484},{"period":"1year","weight":0.7061},{"period":"ytd","weight":0.3388}],"compareEarnings":[{"period":"1week","weight":0.0338},{"period":"1month","weight":0.1254},{"period":"3month","weight":0.1709},{"period":"6month","weight":0.3901},{"period":"1year","weight":0.4543},{"period":"ytd","weight":0.1856}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"三生制药是一家主要从事开发、生产、营销及销售医药产品的投资控股公司。该公司的主要产品包括重组人血小板生成素产品,肿瘤坏死因子α抑制剂产品以及重组人促红素等。产品以特比澳,益赛普,益比奥,以及赛博尔等品牌销售。该公司在国内市场和斯里兰卡、多米尼加共和国及泰国等海外市场销售产品。该公司的子公司包括集思有限公司,香港三生医疗有限公司和沈阳三生制药有限责任公司。该公司通过其子公司还从事项目管理及咨询业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.003645},{"month":2,"riseRate":0.5,"avgChangeRate":0.007788},{"month":3,"riseRate":0.8,"avgChangeRate":0.069279},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.015967},{"month":5,"riseRate":0.666667,"avgChangeRate":0.057469},{"month":6,"riseRate":0.777778,"avgChangeRate":0.012147},{"month":7,"riseRate":0,"avgChangeRate":-0.078897},{"month":8,"riseRate":0.4,"avgChangeRate":-0.006345},{"month":9,"riseRate":0.6,"avgChangeRate":0.027364},{"month":10,"riseRate":0.4,"avgChangeRate":-0.022784},{"month":11,"riseRate":0.7,"avgChangeRate":0.064392},{"month":12,"riseRate":0.5,"avgChangeRate":-0.027233}],"exchange":"SEHK","name":"三生制药","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.5","shortVersion":"4.31.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生制药,01530,三生制药股票,三生制药股票老虎,三生制药股票老虎国际,三生制药行情,三生制药股票行情,三生制药股价,三生制药股市,三生制药股票价格,三生制药股票交易,三生制药股票购买,三生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}